Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Consensus and Guidelines · June 06, 2023

Levodopa Dose Equivalency in Parkinson's Disease

Movement Disorders: Official Journal of the Movement Disorder Society


Additional Info

Disclosure statements are available on the authors' profiles:

Movement Disorders: Official Journal of the Movement Disorder Society
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
Mov. Disord. 2023 May 05;[EPub Ahead of Print], ST Jost, MA Kaldenbach, A Antonini, P Martinez-Martin, L Timmermann, P Odin, R Katzenschlager, R Borgohain, A Fasano, F Stocchi, N Hattori, PL Kukkle, M Rodríguez-Violante, C Falup-Pecurariu, S Schade, JN Petry-Schmelzer, V Metta, D Weintraub, G Deuschl, AJ Espay, EK Tan, R Bhidayasiri, VSC Fung, F Cardoso, C Trenkwalder, P Jenner, K Ray Chaudhuri, HS Dafsari

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading